Health Insurers Want More Data On Clinical Utility of Molecular, Genetic Tests

CEO SUMMARY: Genetic tests that lack two essentials are troublesome for the nation’s health insurers. Those essentials are clinical validity and clinical utility. During a recent webinar, two executives from major health insurers stressed the need for genetic testing labs to provide acceptable evidence that their genetic test is accurate and that it produces information

Tags: all lab tests, american pathology, brca test, brca testing, clia, CLIA certification, clinical lab, clinical lab scientist, clinical laboratories, clinical labs, college of american pathology, cost of genetic testing, Diagnostic tests, generation sequencing, genetic test, genetic testing, genetic testing for, genetic testing lab, genetic testing labs, genetic tests, hie, impac, lab accreditation, lab operation, lab operations, lab test, lab testing, lab tests, laboratories, laboratory accreditation, molecular testing, pathologists, proficiency testing, quality improvement, test for prostate cancer